Astex Pharmaceuticals (ASTX) Halted Ahead of FDA Panel Meeting
Tweet
Share
E-mailGet Alerts ASTX Hot Sheet
Join SI Premium – FREE
Astex Pharmaceuticals, Inc. (Nasdaq: ASTX) was halted for trading earlier ahead of FDA panel meeting.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA: issues early alert on Abiomed heart pump controller purge cassette issue
- Xenon to present phase 3 azetukalner data at European Epilepsy Congress
- Nomad Power Solutions gets DOE nod for Vermont storage project Phase 3
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
